Your Crystallisation, Solid State and Preformulation Partner
Maximise the chance of your small molecule success. Leverage CatSci’s 20+ years’ collective experience in crystallisation, solid state and preformulation.
Speak to our experts about your crystallisation, solid state and preformulation projects
· Solvent screening including solubility and stability testing
· Temperature solubility profiling of selected solvent systems using Technobis Crystal16
· Process Modelling in Dynochem to create initial process design including initial and final temperatures and solvent compositions, as well as seeding temperature and composition
· Small scale testing of process designs using Technobis Crystalline
· In-depth review of available data on API and particle properties, as well as a more holistic approach view of the project and intended use case to identify risks early in the timelines and work on mitigation strategies
· Small scale experiments imaged using built-in optics in the Technobis Crystalline
· 250 mL – 2L scale crystallisations can be monitored using a Blazemetrics Blaze900 PAT probe to monitor the Chord Length Distribution throughout the process. This allows optimisation of seeding parameters as well as heating and cooling rates
· Measurement of filter cake resistance and compressibility to inform filtration time on scale
· Cake washing assessment to determine the appropriate number of washing cycles
Why Choose CatSci?
Crystallisation and Solid State Expertise
Dr Robert Dennehy, our Director of Material Sciences leads our material sciences team. Robert has 20+ years of Large Pharma experience in the field of crystallisation and solid state of pharmaceuticals.
His industry experience and integrated approach to particle science and preformulation development allow him to solve customers’ problems effectively with a high degree of scientific rigour.
Through our end-in-mind approach we link particle science to formulation and process understanding, maximising the chance of your small molecule success
Our integrated chemical development, material science, preformulation and analytical development teams offer a holistic approach to medicines development, breaking down the barriers between drug substance and drug product.
SmartPath is our innovative digital tool that risk assesses your API, project, and formulation data and offers actionable mitigation strategies from our crystallisation and solid state expert, Dr Robert Dennehy.
When it comes to your API project you need to know what the risks are, the threat they pose, and how to alleviate them. SmartPath eliminates the guesswork and presents you with answers.